Technical Analysis for FPRX - Five Prime Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 10.04 -1.95% -0.20
FPRX closed down 1.95 percent on Wednesday, January 16, 2019, on 88 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical FPRX trend table...

Date Alert Name Type % Chg
Jan 16 New Uptrend Bullish 0.00%
Jan 16 Doji - Bearish? Reversal 0.00%
Jan 16 Multiple of Ten Bullish Other 0.00%
Jan 16 Weak + Overbought Other 0.00%
Jan 16 Weak, Overbought and Reversal Signs Reversal 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 16 Upper Bollinger Band Touch Strength 0.00%
Jan 15 Multiple of Ten Bullish Other -1.95%
Jan 15 Weak + Overbought Other -1.95%
Jan 15 Outside Day Range Expansion -1.95%

Older signals for FPRX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company's product candidates include FP-1039/GSK3052230, a protein therapeutic is in PhaseIb clinical trials for trapping and neutralizing cancer-promoting fibroblast growth factors (FGFs) involved in cancer cell proliferation and new blood vessel formation; FPA008, an antibody that inhibits colony stimulating factor-1 receptor; and FPA144 is an antibody for inhibiting FGF receptor 2b, as well as to treat patients with gastric cancer and potentially other solid tumors. It has collaboration and license agreements with GlaxoSmithKline LLC, Glaxo Group Limited, GSK-HGS, Pfizer Inc., and UCB Pharma S.A. The company was founded in 2001 and is headquartered in South San Francisco, California.
Is FPRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 22.845
52 Week Low 7.84
Average Volume 393,855
200-Day Moving Average 14.4504
50-Day Moving Average 10.7348
20-Day Moving Average 9.1005
10-Day Moving Average 9.488
Average True Range 0.6738
ADX 25.82
+DI 20.576
-DI 19.7033
Chandelier Exit (Long, 3 ATRs ) 8.5586
Chandelier Exit (Short, 3 ATRs ) 9.8614
Upper Bollinger Band 10.2679
Lower Bollinger Band 7.9331
Percent B (%b) 0.9
BandWidth 25.655733
MACD Line -0.2554
MACD Signal Line -0.4961
MACD Histogram 0.2407
Fundamentals Value
Market Cap 281.92 Million
Num Shares 28.1 Million
EPS -4.26
Price-to-Earnings (P/E) Ratio -2.36
Price-to-Sales 37.28
Price-to-Book 3.79
PEG Ratio 0.14
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.66
Resistance 3 (R3) 11.66 11.12 11.39
Resistance 2 (R2) 11.12 10.71 11.12 11.30
Resistance 1 (R1) 10.58 10.45 10.85 10.58 11.21
Pivot Point 10.04 10.04 10.18 10.04 10.04
Support 1 (S1) 9.50 9.63 9.77 9.50 8.87
Support 2 (S2) 8.96 9.37 8.96 8.78
Support 3 (S3) 8.42 8.96 8.69
Support 4 (S4) 8.42